Pharmacy OneSource Blog

Weekly Healthcare Roundup: Antibiotics, Opioids Commonly Used and Often Worthless, Chantix Boxed Label Warning Removed

Posted on 12/21/16

5_common_staff_reactions_to_automated_scheduling_pharmacy.jpg

Here are some of this week's top headlines in healthcare:

Healthcare Industry, Pharmacy and Infection Prevention News

  • Antibiotics, Opioids Commonly Used and Often Worthless
    MedPage Today
  • SHEA Teams Up with CDC to Develop Outbreak Training Resources
    Infection Control Today
  • Long-term anti-inflammatory drug use may increase cancer-related deaths for certain patients
    Science Daily
  • Pharmacies miss half of dangerous drug combinations
    Chicago Tribune
  • After harsh light, a cheaper version of EpiPen from Mylan
    Associated Press

FDA Approvals, New Drug Applications and Notices

  • Clovis Oncology spikes; receives early FDA approval for advanced cancer drug
    CNBC
  • FDA approves removal of boxed label warning from Pfizer’s Chantix
    Drug Store News
  • FDA OKs CytomX's IND for lead product candidate
    Seeking Alpha
  • Ironshore Pharmaceuticals Announces FDA Acceptance of HLD200 New Drug Application for Treatment of ADHD
    Business Wire
  • AbbVie Submits New Drug Application to U.S. FDA for its Investigational Regimen of Glecaprevir/Pibrentasvir
    PR Newswire
usp 797 success

Topics: Weekly Healthcare Roundup

About the Author

Heather Quitos is the Digital Marketing Manager for Pharmacy OneSource.